Fidelity Investments’s Avalyn Pharma AVLN Stock Holding History
Bought
Maintained
Sold
Other funds holding AVLN
Fidelity Investments's AVLN Position: Q3 2026 in Review
Fidelity Investments increased its Avalyn Pharma (AVLN) stake by 6% in Q3 2026, buying an estimated $11.3M and bringing the position to 6,185,994 shares worth $176M. The position accounts for 0.01% of the portfolio, ranked #985.
Fidelity Investments first reported a position in AVLN in Q2 2026 and has held it in 2 quarters since. The position peaked at $192M in Q2 2026. 116 funds tracked by Wall St. Rank hold AVLN as of Q3 2026.
- Fidelity Investments held 6,185,994 shares of Avalyn Pharma worth $176M as of Q3 2026.
- Fidelity Investments bought 350,735 Avalyn Pharma shares in Q3 2026, an estimated $11.3M.
- Avalyn Pharma made up 0.01% of Fidelity Investments's portfolio in Q3 2026, its #985 holding.
- Fidelity Investments first reported a position in Avalyn Pharma in Q2 2026 and has held it in 2 quarters since.
- Fidelity Investments's Avalyn Pharma position peaked at $192M in Q2 2026.
- 116 funds tracked by Wall St. Rank held Avalyn Pharma as of Q3 2026.
Based on Fidelity Investments's 13F filing for Q3 2026, filed 10 Nov 2026.